07:00 , Aug 19, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Acute lymphoblastic leukemia (ALL) IL-23; microRNA-15a (miR-15a) In vitro and mouse studies suggest that IL-23 and miR-15a could help treat pediatric ALL. In ALL...
07:00 , May 13, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Neurology Stroke MicroRNA-15a (miR-15a); peroxisome proliferation-activated receptor-d (PPARD; PPARd) A study in mice and in cell culture suggests that increasing PPARd signaling could help protect...
07:00 , Apr 30, 2009 |  BC Innovations  |  Cover Story

miRNAs sounding better

Hearing loss is a field that has been totally refractory to drug treatment. Now, British and Spanish researchers have converged on microRNA-96, or elements downstream of it, as a potential therapeutic target for treating age-related...
07:00 , Apr 23, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Other

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Other Hearing loss MicroRNA-15a -1 (miRNA-15a-1); miRNA-18a Studies in mice and in zebrafish suggest that targeting a series of miRNAs in the...
07:00 , Apr 10, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Cancer Chronic lymphocytic leukemia (CLL) miR-15a; miR-16-1 A study of a leukemia cell line and primary samples from CLL patients identified a coexpressed gene signature that could be useful for diagnosing...